Syverson Strege & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-474
Closed -$38.2K – 395
2023
Q1
$38.2K Buy
474
+133
+39% +$10.8K 0.02% 143
2022
Q4
$26.5K Buy
341
+118
+53% +$9.56K 0.01% 160
2022
Q3
$18K Sell
223
-79
-26% -$7.1K 0.01% 165
2022
Q2
$27K Buy
302
+38
+14% +$3.85K 0.01% 168
2022
Q1
$29K Buy
+264
New +$27.9K 0.03% 151
2021
Q4
– Sell
-4
Closed -$1K – 416
2021
Q3
$1K Hold
4
– – ﹤0.01% 432
2021
Q2
$0 Hold
4
– – ﹤0.01% 280
2021
Q1
$0 Hold
4
– – ﹤0.01% 275
2020
Q4
$0 Buy
+4
New +$440 ﹤0.01% 249

Other funds holding MDT

Syverson Strege & Co's MDT Position: Q2 2023 in Review

Syverson Strege & Co sold out of Medtronic (MDT) in Q2 2023, closing a stake of 474 shares — an estimated $38.2K sold.

Syverson Strege & Co first reported a position in MDT in Q4 2020 and held it in 9 quarters. The position peaked at $38.2K in Q1 2023. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Syverson Strege & Co reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 474 Medtronic shares in Q2 2023, an estimated $38.2K.
  • Syverson Strege & Co first reported a position in Medtronic in Q4 2020 and held it in 9 quarters.
  • Syverson Strege & Co's Medtronic position peaked at $38.2K in Q1 2023.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.